Larkspur Health Acquisition units may separate into common stock and warrants starting Feb 10, 2022

ZyVersa Therapeutics, Inc.

Units trade as LSPRU; separated common stock as LSPR, warrants as LSPRW on Nasdaq.
Separation effective February 10, 2022; holders must contact transfer agent Continental Stock Transfer.
No fractional warrants will be issued; only whole warrants will trade separately.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.